Exicure HiTron Reacquires 623K Shares, Lifts Stake to 34.87% Amid Exicure's Financial Distress
XCUR is trading near its 52-week low of $1.43 (14% above the low).
Summary
Exicure HiTron Inc. reacquired 623,275 shares of Exicure, Inc. at $4.50 per share, increasing its stake to 34.87%. The $2.8 million transaction was executed via share transfer amendments, not open-market purchases, and comes as Exicure battles severe financial distress.
Key Events · Ownership and Investor Activity · XCUR
-
Major Stake Increase
Exicure HiTron reacquired 623,275 shares at $4.50 each, boosting its ownership to 2,222,224 shares or 34.87% of Exicure, Inc.
-
Transaction Structure
Shares were returned via share transfer amendment agreements with prior transferees, not through open-market purchases. Voting power reverted only after transfer agent recording.
-
Financial Context
The $2.8 million reacquisition occurs as Exicure faces a going concern warning, dwindling cash, and Nasdaq non-compliance, raising questions about the strategic intent behind the increased stake.
-
Price Disconnect
The $4.50 per share reacquisition price is significantly above the current $1.63 market price, indicating the transaction was based on prior agreements rather than current market conditions.
Analysis · XCUR · Life Sciences
Exicure HiTron Inc., a 10% owner, reacquired 623,275 shares at $4.50 per share — a total value of $2.8 million — through share transfer amendment agreements, not open-market purchases. The reacquisition raises its stake to 34.87% of Exicure, a biotech facing a going concern warning and Nasdaq non-compliance. While the transaction signals commitment from a major shareholder, the $4.50 price is nearly triple the current $1.63 stock price, suggesting the reacquisition was structured under prior agreements rather than reflecting current market value. The increased ownership could influence upcoming strategic decisions, including potential financing or restructuring efforts.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 29.6% of the 1725 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.33%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XCUR was trading at $1.63 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.7M. The 52-week trading range was $1.43 to $9.50. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.